Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10

Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia

Total article views   Abstract views HTML views PDF downloads Totals
2,137 Dovepress* 1,864 191+ 203 2,055
PubMed Central* 0 82 48 82
Totals 1,864 273 251 2,137
*Since 1 November 2018
+Since July 2016

View citations on PubMed Central and Google Scholar